[Pharmaceutical interventions in the new medicine service].
Barris Blundell D +3 more
europepmc +3 more sources
ID187 O Impacto do Registro Acelerado de Medicamentos pela Anvisa no Cenário Regulatório Brasileiro
Introdução Complexidade das moléculas, quanto na escolha dos alvos terapêuticos. A celeridade no registro de novos produtos farmacêuticos é altamente desejada, principalmente em condições sem alternativas disponíveis. No entanto, a registro acelerados desses medicamentos, também chamado de fast-track, pode comprometer a qualidade dos estudos.
Marcus Carvalho Borin +2 more
openaire +1 more source
[Patient safety during the dispensing service in community pharmacies in the event of a prescribing error. A case report]. [PDF]
Pérez Rodríguez RO +1 more
europepmc +1 more source
Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024. [PDF]
Silva SN, Saliba MF, Ribeiro LR, Cota G.
europepmc +1 more source
[Authorization for off-label use may not be beneficial for the Brazilian Unified National Health System]. [PDF]
Caetano R +3 more
europepmc +1 more source
Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]
Caffaratti M +9 more
europepmc +1 more source
Generic medicinal products have an important role in the pharmaceutical market due to the fact that they provide with medicinal product therapeutically equivalents to a reference innovator medicinal product but at more competitive prices. Pharmaceutical industry of generic medicines with an international vision needs an harmonised regulation which ...
openaire +2 more sources
Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]
Panesso GA +7 more
europepmc +1 more source
[Pharmaceutical services in expanded access, compassionate use, and post-trial access: the perspective of clinical researchers]. [PDF]
Silva MBFCD, Silva CFD, Silva MJSD.
europepmc +1 more source
[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]
Marín GH +7 more
europepmc +1 more source

